Prof Dan S. Suesskind
Teva Board of Directors
Dan S. Suesskind, joined Teva's Board of Directors in September 2017. Mr. Suesskind previously served as a director of Teva from 1981 to 2001 and from 2010 to 2014. He was Teva's Chief Financial Officer from 1977 until 2008. Currently, Mr. Suesskind serves as a director of Israel Corporation Ltd. and Redhill Biopharma Ltd., as well as a member on the Board of the Jerusalem Foundation, as a member of the Investment Committee of Ben Gurion University, as a member of the Investment Committee of the Israel Academy of Science and Humanities and as a member of the Board of Trustees of the Hebrew University. He served on the Board of Gefen Biomed Investments Ltd. from 2010 until March 2013, on the Board of Migdal Insurance Company Ltd. from 2002 until 2013, and on the Board of Syneron Medical Ltd.